Browse by People

Collapse authors list.
Hykin, Philip, Prevost, A Toby, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Hounsome, Barry, Yang, Yit, Harding, Simon P ORCID: 0000-0003-4676-1158, Lotery, Andrew et al (show 63 more authors) , Chakravarthy, Usha, Sivaprasad, Sobha, Eleftheriadis, Haralabos, Briggs, Michael, Williams, Michael, Abugreen, Salwa, Ghanchi, Faruque, Narendran, Nirodhini, Hughes, Edward, Ross, Adam, Gupta, Nitin, Turner, Stephen, Osoba, Yinka, Patel, Jignesh, Pagliarini, Sergio, Lip, Peck-Lin, Patel, Nishal, Jafree, Afsar, Menon, Geeta, Patra, Sudeshna, Burton, Ben, Taylor, Simon, Mackenzie, Sarah, Gale, Richard, Vadivelu, Komala, McKibbin, Martin, George, Sheena, Almeida, Goncalo, Sen, Piyali, Patrao, Namritha, Menon, Deepthy, Nicholson, Luke, D'Souza, Yvonne, Talks, James, Sundaram, Venki, Banerjee, Sanjiv, Habib, Maged, Ram, Raghu, Brand, Christopher, Newman, Douglas, Gilmour, David, Kelly, Simon, Khan, Rehna, Empeslidis, Theo, Jones, Colin, Fletcher, Emily, Downey, Louise, Younis, Saad, Severn, Philip, Prakash, Priya, Lever, Ellen, Downes, Susan, Stratton, Irene, Dodhia, Hiten, Fell, Greg, Asaria, Riaz, Byrne, Jonathan, Burgess, Vanessa, Powling, Alison, Ryde, Melba, Walker, Sarah, Moorman, Consuela and Dhillon, Baljean (2019) Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion A Randomized Clinical Trial. JAMA OPHTHALMOLOGY, 137 (11). pp. 1256-1264.

Collapse authors list.
Hykin, Philip, Prevost, A Toby, Sivaprasad, Sobha, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Alshreef, Abualbishr, Flight, Laura, Pennington, Rebekah et al (show 9 more authors) , Hounsome, Barry, Lever, Ellen, Metry, Andrew, Poku, Edith, Yang, Yit, Harding, Simon P ORCID: 0000-0003-4676-1158, Lotery, Andrew, Chakravarthy, Usha and Brazier, John (2021) Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. HEALTH TECHNOLOGY ASSESSMENT, 25 (38). 1-+.